- Home
- CSTL vs OST Comparison
CSTL vs OST Comparison
Compare CSTL & OST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- OST
- Stock Information
- Founded
- CSTL 2007
- OST 2010
- Country
- CSTL United States
- OST China
- Employees
- CSTL N/A
- OST N/A
- Industry
- CSTL Medical Specialities
- OST Industrial Machinery/Components
- Sector
- CSTL Health Care
- OST Technology
- Exchange
- CSTL Nasdaq
- OST Nasdaq
- Market Cap
- CSTL 561.9M
- OST 601.6M
- IPO Year
- CSTL 2019
- OST 2022
- Fundamental
- Price
- CSTL $16.53
- OST $0.12
- Analyst Decision
- CSTL Strong Buy
- OST
- Analyst Count
- CSTL 6
- OST 0
- Target Price
- CSTL $37.67
- OST N/A
- AVG Volume (30 Days)
- CSTL 396.8K
- OST 44.0M
- Earning Date
- CSTL 08-04-2025
- OST 08-25-2025
- Dividend Yield
- CSTL N/A
- OST N/A
- EPS Growth
- CSTL N/A
- OST N/A
- EPS
- CSTL N/A
- OST N/A
- Revenue
- CSTL $347,083,000.00
- OST $38,333,251.00
- Revenue This Year
- CSTL N/A
- OST N/A
- Revenue Next Year
- CSTL $1.36
- OST N/A
- P/E Ratio
- CSTL N/A
- OST N/A
- Revenue Growth
- CSTL 38.43
- OST 0.34
- 52 Week Low
- CSTL $15.45
- OST $0.12
- 52 Week High
- CSTL $35.84
- OST $9.40
- Technical
- Relative Strength Index (RSI)
- CSTL 34.83
- OST 24.87
- Support Level
- CSTL $19.29
- OST $0.12
- Resistance Level
- CSTL $20.26
- OST $0.14
- Average True Range (ATR)
- CSTL 0.70
- OST 0.03
- MACD
- CSTL -0.35
- OST -0.02
- Stochastic Oscillator
- CSTL 4.44
- OST 1.78
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.